This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Nearly two months after Digene sued Third Wave Technologies for allegedly infringing its human papillomavirus intellectual property, Third Wave last week filed a countersuit with the US District Court for the Western District of Wisconsin, alleging that Digene has “abused its monopoly power to thwart competition” in the HPV diagnostics market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.